53 related articles for article (PubMed ID: 12530097)
1. The prognostic significance of epithelial-mesenchymal transition in breast cancer.
Fuchs IB; Lichtenegger W; Buehler H; Henrich W; Stein H; Kleine-Tebbe A; Schaller G
Anticancer Res; 2002; 22(6A):3415-9. PubMed ID: 12530097
[TBL] [Abstract][Full Text] [Related]
2. PTRH2: an adhesion regulated molecular switch at the nexus of life, death, and differentiation.
Corpuz AD; Ramos JW; Matter ML
Cell Death Discov; 2020 Nov; 6(1):124. PubMed ID: 33298880
[TBL] [Abstract][Full Text] [Related]
3. EMT Markers in Locally-Advanced Prostate Cancer: Predicting Recurrence?
Cheaito KA; Bahmad HF; Hadadeh O; Saleh E; Dagher C; Hammoud MS; Shahait M; Mrad ZA; Nassif S; Tawil A; Bulbul M; Khauli R; Wazzan W; Nasr R; Shamseddine A; Temraz S; El-Sabban ME; El-Hajj A; Mukherji D; Abou-Kheir W
Front Oncol; 2019; 9():131. PubMed ID: 30915272
[No Abstract] [Full Text] [Related]
4. The Kindlin-2 regulation of epithelial-to-mesenchymal transition in breast cancer metastasis is mediated through miR-200b.
Sossey-Alaoui K; Pluskota E; Szpak D; Schiemann WP; Plow EF
Sci Rep; 2018 May; 8(1):7360. PubMed ID: 29743493
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal transition in breast epithelial cells treated with cadmium and the role of Snail.
Wei Z; Shan Z; Shaikh ZA
Toxicol Appl Pharmacol; 2018 Apr; 344():46-55. PubMed ID: 29501589
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in the thyroid.
Boufraqech M; Klubo-Gwiezdzinska J; Kebebew E
Best Pract Res Clin Endocrinol Metab; 2016 Oct; 30(5):603-619. PubMed ID: 27923454
[TBL] [Abstract][Full Text] [Related]
7. Cross Talk Mechanism among EMT, ROS, and Histone Acetylation in Phorbol Ester-Treated Human Breast Cancer MCF-7 Cells.
Kamiya T; Goto A; Kurokawa E; Hara H; Adachi T
Oxid Med Cell Longev; 2016; 2016():1284372. PubMed ID: 27127545
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancer.
Verrill C; Cerundolo L; Mckee C; White M; Kartsonaki C; Fryer E; Morris E; Brewster S; Ratnayaka I; Marsden L; Lilja H; Muschel R; Lu X; Hamdy F; Bryant RJ
Oncotarget; 2016 Jan; 7(2):1107-19. PubMed ID: 26701730
[TBL] [Abstract][Full Text] [Related]
9. Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death.
Narayanan KB; Ali M; Barclay BJ; Cheng QS; D'Abronzo L; Dornetshuber-Fleiss R; Ghosh PM; Gonzalez Guzman MJ; Lee TJ; Leung PS; Li L; Luanpitpong S; Ratovitski E; Rojanasakul Y; Romano MF; Romano S; Sinha RK; Yedjou C; Al-Mulla F; Al-Temaimi R; Amedei A; Brown DG; Ryan EP; Colacci A; Hamid RA; Mondello C; Raju J; Salem HK; Woodrick J; Scovassi AI; Singh N; Vaccari M; Roy R; Forte S; Memeo L; Kim SY; Bisson WH; Lowe L; Park HH
Carcinogenesis; 2015 Jun; 36 Suppl 1(Suppl 1):S89-110. PubMed ID: 26106145
[TBL] [Abstract][Full Text] [Related]
10. Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines.
Cursons J; Leuchowius KJ; Waltham M; Tomaskovic-Crook E; Foroutan M; Bracken CP; Redfern A; Crampin EJ; Street I; Davis MJ; Thompson EW
Cell Commun Signal; 2015 May; 13():26. PubMed ID: 25975820
[TBL] [Abstract][Full Text] [Related]
11. KRAS and YAP1 converge to regulate EMT and tumor survival.
Shao DD; Xue W; Krall EB; Bhutkar A; Piccioni F; Wang X; Schinzel AC; Sood S; Rosenbluh J; Kim JW; Zwang Y; Roberts TM; Root DE; Jacks T; Hahn WC
Cell; 2014 Jul; 158(1):171-84. PubMed ID: 24954536
[TBL] [Abstract][Full Text] [Related]
12. Cripto-1 expression in glioblastoma multiforme.
Pilgaard L; Mortensen JH; Henriksen M; Olesen P; Sørensen P; Laursen R; Vyberg M; Agger R; Zachar V; Moos T; Duroux M
Brain Pathol; 2014 Jul; 24(4):360-70. PubMed ID: 24521322
[TBL] [Abstract][Full Text] [Related]
13. Inferring microRNA and transcription factor regulatory networks in heterogeneous data.
Le TD; Liu L; Liu B; Tsykin A; Goodall GJ; Satou K; Li J
BMC Bioinformatics; 2013 Mar; 14():92. PubMed ID: 23497388
[TBL] [Abstract][Full Text] [Related]
14. Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.
Payne CM; Crowley-Skillicorn C; Bernstein C; Holubec H; Bernstein H
Clin Exp Gastroenterol; 2011; 4():75-119. PubMed ID: 21753893
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?
Dunning NL; Laversin SA; Miles AK; Rees RC
Cancer Immunol Immunother; 2011 Aug; 60(8):1181-93. PubMed ID: 21688178
[TBL] [Abstract][Full Text] [Related]
16. ASK-ing EMT not to spread cancer.
Kyprianou N
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):2731-2. PubMed ID: 20145111
[No Abstract] [Full Text] [Related]
17. Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells.
Zhu ML; Kyprianou N
FASEB J; 2010 Mar; 24(3):769-77. PubMed ID: 19901020
[TBL] [Abstract][Full Text] [Related]
18. The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion.
Sossey-Alaoui K; Bialkowska K; Plow EF
J Biol Chem; 2009 Nov; 284(48):33019-29. PubMed ID: 19801681
[TBL] [Abstract][Full Text] [Related]
19. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression.
Peter ME
Cell Cycle; 2009 Mar; 8(6):843-52. PubMed ID: 19221491
[TBL] [Abstract][Full Text] [Related]
20. Msx2 induces epithelial-mesenchymal transition in mouse mammary epithelial cells through upregulation of Cripto-1.
di Bari MG; Ginsburg E; Plant J; Strizzi L; Salomon DS; Vonderhaar BK
J Cell Physiol; 2009 Jun; 219(3):659-66. PubMed ID: 19170109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
